Mendel Kaelen
Founder and CEO of Wavepaths, Neuroscientist
Data updated
Research Footprint
Mendel Kaelen appears in 38 tracked papers (2013–2026), most studied alongside LSD, Psilocybin and Ayahuasca, across Depressive Disorders, Neuroimaging & Brain Measures and Healthy Volunteers.
Most-cited paper: Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (1520 citations).
Frequent co-authors: Robin Carhart-Harris, David Nutt and Leor Roseman.
Publication Landscape
How the 38 papers Blossom tracks for Mendel Kaelen line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Mendel Kaelen's publishing grown?
SourcedTracked papers by publication year. Click a year for the running total.
Don't read as total output: only the 38 of 38 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Mendel Kaelen publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Mendel Kaelen publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Mendel Kaelen is a neuroscientist known for his foundational research at Imperial College London on the synergy between music and psychedelics. His work demonstrated how music-evoked emotion is enhanced by psychedelics and plays a central role in therapeutic breakthrough. He founded Wavepaths to translate these scientific insights into personalized music environments for healthcare.
Key Impact
The foremost researcher on the critical role of music in facilitating therapeutic outcomes in psychedelic medicine.
Collaboration Network
49 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Mendel Kaelen's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Mendel Kaelen is associated with.
Imperial College London
academicThe Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).
View stakeholder →Wavepaths
Wavepaths is a digital platform, founded by the neuroscientist Mendel Kaelen, that delivers adaptive, generative music designed for psychedelic and other therapy sessions. Its software responds in real time to the arc of a session, giving therapists tools to shape the musical environment that supports psychedelic-assisted and consciousness-altering therapeutic work.
View stakeholder →